Phase III clinical trial of MN-10-T for primary osteoporosis

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080220434

Enrollment

500

Registered

2007-09-03

Start date

2007-09-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary osteoporosis

Interventions

investigational material(s) Generic name etc : MN-10-T INN of investigational material : Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Administration for Investigati

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -Patients with prevalent fragile vertebral fractures -Patients who have low bone mineral density

Exclusion criteria

Exclusion criteria: Patient who have a metabolic bone disorder other than osteoporosis

Design outcomes

Primary

Measure	Time frame
Incidence of new vertebral fractures	—

Secondary

Measure	Time frame
Percent changes in the lumbar spine bone mineral density	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026